Clinical Trial Update: Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating enteric-coated mycophenolate sodium (EC-MPS) and mycophenolate mofetil (MMF) in renal transplant patients with GI intolerance;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• Enteric-coated mycophenolate sodium (mycophenolate sodium)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Renal Transplantation | Phase 4 | Status: COMPLETED | Results posted: 2011-08-15